HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 0.29
Day range
kr 0.28 - kr 0.29
Year range
kr 0.18 - kr 0.72
Market cap
97.39M SEK
Avg Volume
199.51K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.35M | 23.12% |
Net income | -12.46M | -23.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -12.30M | -23.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.87M | -61.51% |
Total assets | 11.81M | -51.67% |
Total liabilities | 5.47M | 24.34% |
Total equity | 6.34M | — |
Shares outstanding | 346.58M | — |
Price to book | 14.50 | — |
Return on assets | -160.07% | — |
Return on capital | -245.42% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -12.46M | -23.34% |
Cash from operations | -13.54M | -16.25% |
Cash from investing | — | — |
Cash from financing | -10.00K | -101.14% |
Net change in cash | -13.54M | -26.97% |
Free cash flow | -8.80M | -12.61% |
About
Founded
2014
Website
Employees
4